Recent-Onset Diabetes Tied to Increased Pancreatic Cancer Risk

Share this content:
Recent-Onset Diabetes Tied to Increased Pancreatic Cancer Risk
Recent-Onset Diabetes Tied to Increased Pancreatic Cancer Risk

TUESDAY, June 19, 2018 (HealthDay News) -- Recent-onset diabetes is associated with more than a two-fold greater increase in risk of pancreatic cancer (PC) than long-standing diabetes in African-Americans and Latinos, according to a study published online June 18 in the Journal of the National Cancer Institute.

Veronica Wendy Setiawan, Ph.D., from the University of Southern California in Los Angeles, and colleagues examined the relationships between recent-onset diabetes and PC incidence in 48,995 African-Americans and Latinos in the Multiethnic Cohort (baseline 1993 to 1996).

The researchers found that 32.3 percent of participants developed diabetes between baseline and 2013, and 408 incident PC cases were identified during follow-up. Diabetes was associated with PC (hazard ratio [HR] at age 75 years, 2.39). For individuals with onset of diabetes within three years of PC diagnosis, there was greater risk compared with those with long-term diabetes across all ages. At age 75 years, the HR for recent-onset diabetes was 4.08 in Latinos and 3.38 in African-Americans.

"Our findings support the hypothesis that recent-onset diabetes is a manifestation of PC and that long-standing diabetes is a risk factor for this malignancy," the authors write.

Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

CDC: Increase Seen in Salmonella Illnesses From Ground Beef

CDC: Increase Seen in <i>Salmonella</i> Illnesses From Ground ...

246 people now sickened; 59 people have been hospitalized; no deaths reported to date

Epinephrine Personal Autoinjectors Cost-Effective at 24

Epinephrine Personal Autoinjectors Cost-Effective at &#36;24

Based on 10-fold fatality risk difference, value-based price for personal epinephrine $24

Burden of Liver Cancer Rising in Medicare Patients

Burden of Liver Cancer Rising in Medicare Patients

Coexistence of other liver conditions tied to even higher risk for death, health care costs

is free, fast, and customized just for you!




Already a member?

Sign In Now »